Monoclonal antibodies (mAbs) targeting bacterial virulence factors may represent promising therapeutics in the fight against severe bacterial infections. Here, we present an approach for developing human-derived antibodies targeting the type III secretion system (T3SS) of Pseudomonas aeruginosa (PA) by neutralizing the function of the T3SS-tip protein PcrV. The protocol involves identifying individuals with protective antibodies, isolating PcrV-specific B cells from these individuals, and producing and testing anti-PcrV mAbs derived from single B cells. For complete details on the use and execution of this protocol, please refer to Simonis et al.1.
Keywords: biotechnology and bioengineering; cell biology; cell culture; cell isolation; cell-based assays; immunology; microbiology; molecular biology; single cell.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.